Magnesium lithospermate B ameliorates cisplatin-induced injury cultured renal epithelial cells

Experimental and Toxicologic Pathology

Volumn 49, Issue 5, 1997, Pages 343-346

  Yokozawa, Takako ^a   Dong, Erbo ^a   Oura, Hikokichi ^a   Nonaka, Gen Ichiro ^b   Nishioka, Itsuo ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Cisplatin; Lactate dehydrogenase; LLC PK1; Magnesium lithospermate B; Malondialdehyde; Renal injury

Indexed keywords

CISPLATIN; LACTATE DEHYDROGENASE; MAGNESIUM LITHOSPERMATE; MALONALDEHYDE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; KIDNEY EPITHELIUM; KIDNEY INJURY; NONHUMAN;

EID: 0031450806     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0940-2993(97)80104-2     Document Type: Article

References (20)

1. BLACHLEY JD, HILL JB: Renal and electrolyte disturbance associated with cisplatin. Ann Intern Med 1981; 95: 628-632.
2. GASTRAUNTHALER GJA: Epithelial cells in tissue culture. Renal Physiol Biochem 1988; 11: 1-42.
3. GEMBA M: Cisplatin-induced acute renal failure. Kidney and Dialysis 1991; 31 (special vol): 421-425.
4. GEMBA M, FUKUISHI N: Amelioration by ascorbic acid of cisplatin-induced injury in cultured renal epithelial cells. In KOIDE H, ENDOU H, KUROKAWA K (eds.): Cellular and Molecular Biology of the Kidney. Contributions to Nephrology. S. Karger, Basel 1991, pp. 138-142.
5. GEMBA M, MATSUSHITA T, FUJISAWA C et al.: Enhancement by glutathione depletion of cisplatin-induced nephrotoxicity in rats: Effect of antioxidant pretreatment. In BACH PH, GREGG NJ, WILKS MF et al. (eds.): Nephrotoxicity. Marcel Dekker, New York 1991, pp. 315-320.
6. GOLDSTEIN RS, MAYOR GH: The nephrotoxicity of cisplatin. Life Sci 1983; 32: 685-690.
7. HANNEMANN J, BAUMANN K: Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengers. Toxicology 1988; 51: 119-132.
8. LITTERST CL: Cisplatinum: A review, with special reference to cellular and molecular interactions. Agents and Actions 1984; 15: 520-524.
9. MCGUINESS JE, PROCTOR PH, DEMOPOULOS HB et al.: Amelioration of cis-platinum nephrotoxicity by Orgotein (superoxide dismutase). Physiol Chem Phys 1978; 10: 267-277.
10. SUGIHARA K, NAKANO S, GEMBA M: Effect of cisplatin on in vitro production of lipid peroxides in rat kidney cortex. Jpn J Pharmacol 1987; 44: 71-76.
11. TANAKA T, MORIMOTO S, NONAKA G et al.: Magnesium and ammonium-potassium lithospermates B, the active principles having a uremia-preventive effect from Salvia miltiorrhiza. Chem Pharm Bull 1989; 37: 340-344.
12. WEINER MW, JACOBS C: Mechanism of cisplatin nephrotoxicity. Federation Proc 1983; 42: 2974-2978.
13. YAGI K: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15: 212-216.
14. YOKOZAWA T, OURA H, LEE TW et al.: Augmentation of renal response by magnesium lithospermate B. Nephron 1991a; 57: 78-83.
15. YOKOZAWA T, CHUNG HY, LEE TW et al.: Potentiating effect of converting enzyme inhibitor captopril to the renal responses of magnesium lithospermate B in rats with adenine-induced renal failure. Chem Pharm Bull 1991 b; 39: 732-736.
16. YOKOZAWA T, LEE TW, OURA H et al.: Effect of magnesium lithospermate B in rats with sodium-induced hypertension and renal failure. Nephron 1992a; 60: 460-465.
17. YOKOZAWA T, LEE TW, OURA H et al.: Haemodynamic effects of magnesium lithospermate B in rats with renal failure. Phytother Res 1992b; 6: 194-199.
18. YOKOZAWA T, LEE TW, OURA H et al.: Renal responses to magnesium lithospermate B in rats with adenine-induced renal failure. Phytother Res 1993a; 7: 235-239.
19. YOKOZAWA T, LEE TW, OURA H et al.: Effect of magnesium lithospermate B on the renal and urinary kallikrein activities in rats with adenine-induced renal failure. Jpn J Nephrol 1993b; 35: 337-342.
20. YOKOZAWA T, DONG E, OURA H et al.: Magnesium lithospermate B suppresses the increase of active oxygen in rats after subtotal nephrectomy. Nephron 1997; 75: 88-93.